Option Care HealthOPCH +0.18%76 EBITDA Margin % is 6.66% as of Mar. 2026, which is 9% below its 10-year median of 7.28. GuruFocus rates OPCH with a GF Score™ of 76/100 and a GF Value™ of $40.20 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, Option Care Health ranks worse than 58.53% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Option Care Health's EBITDA for the
three
months ended in Mar. 2026 was $90 Mil. Option Care Health's Revenue for the
three
months ended in Mar. 2026 was $1,351 Mil. Therefore, Option Care Health's EBITDA margin for the quarter that ended in Mar. 2026 was 6.66%.
Option Care Health (NAS:OPCH) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Option Care Health EBITDA Margin % Related Terms
Option Care Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Option Care Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OPCH vs CON, BKD, LFST: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Option Care Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Option Care Health EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Option Care Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Option Care Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Option Care Health (OPCH) has a EBITDA Margin % of 6.66% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Option Care Health and its competitors. This is near median its historical median of 7.28. Over the past decade, Option Care Health's EBITDA Margin % has ranged from 2.31 to 10.98. According to the industry distribution chart, Option Care Health ranks #391 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 58.5%.
Is Option Care Health's EBITDA Margin % too high?
Option Care Health's current EBITDA Margin % of 6.66% is near median its 10-year median of 7.28. Over the past 10 years, this metric has ranged from a low of 2.31 to a high of 10.98. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Option Care Health's value of 6.66% is 34.8% below this industry median. Based on the distribution chart, Option Care Health ranks #391 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Option Care Health has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Option Care Health's EBITDA Margin % compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, Option Care Health ranks #391 out of 668 companies for EBITDA Margin %. This places Option Care Health in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Option Care Health's value of 6.66% is 34.8% below this benchmark. Historically, Option Care Health's own EBITDA Margin % has ranged from 2.31 to 10.98 over the past decade. While the company's 10-year median is 7.28 vs. the industry median of 10.21, Option Care Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Option Care Health's current EBITDA Margin % of 6.66% is 34.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Option Care Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Option Care Health's current EBITDA Margin % is 6.66%, which is near median its own 10-year median of 7.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Option Care Health stock overvalued right now?
Based on GuruFocus' analysis, Option Care Health (OPCH) is currently considered Significantly Undervalued. The stock's GF Value™ is $40.20, compared to a current price of $22.02 — trading 45.2% below its estimated fair value. The current EBITDA Margin % is 6.66%, which is near median its 10-year median of 7.28 and 34.8% below the Healthcare Providers & Services industry median of 10.21. Option Care Health's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Option Care Health (OPCH), the current EBITDA Margin % is 6.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Option Care Health (OPCH) Overvalued in 2026?
Based on GuruFocus' analysis, Option Care Health stock appears to be undervalued.
The current stock price of $22.02 is trading 45.2% below its estimated GF Value™ of $40.20.
GuruFocus considers Option Care Health to be Significantly Undervalued.
Key valuation signals for OPCH:
EBITDA Margin %: 6.66% (near median its 10-year median of 7.28)
GF Value™: $40.20 vs. price of $22.02 (45.2% below fair value)
Industry Position: 34.8% below the Healthcare Providers & Services median (#391 of 668)
No single metric tells the full story. See the OPCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
76GF Score
Get the complete analysis for OPCH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPCH has been successfully added to your 
